
📢 Exciting news from #ACTG! 🌍 They've published “Pitavastatin to Prevent Cardiovascular Disease in HIV Infection” in #NEJM. The #REPRIEVE trial shows pitavastatin calcium cuts risk of cardiovascular events by 35% in HIV patients over 5 years. #IAS2023
bit.ly/3OsgNLK

English


















